Articles

Exploring the Impact of health-care cost sharing mechanisms in health service users for all the 27 member countries of the EU

Authors: Andreas Siakou and Costas Athanasakis

Medicines optimisation in Northern Ireland - scope and results of a challenging project

Authors: Mike Scott, Frans van Andel and Rob Brenninkmeijer

The effective and innovative cost saving of software in managing unregistered drugs

Authors: Nur Wahida Zulkifli, Noorizan Abd Aziz, Yahaya Hassan, Mohamed Azmi Hassali and Nur Liyana Zainal Bahrin

Pharmaceutical distribution remuneration in Europe

Authors: Sabine Vogler, Lena Lepuschütz and Peter Schneider

Reimbursement measures in European countries – findings of a bibliometric literature review

Authors: Sabine Vogler, Nina Zimmermann, Antonio Olry de Labry and Jaime Espin

The prices outpatients have to pay for purchasing medicines in Armenia

Authors: Irina Kazaryan, Anahit Sevikyan and Margarit Melikyan

Access of high technology medicines in Russia

Authors: Liudmila Bezmelnitsyna, Dmitry Meshkov and Ramil Khabriev

Optimising prescribing in primary care: an evaluation of financial and clinical parameters

Authors: Asal Albayati, David Lu, Liam Sergeant, Nandita Singh, Keith Crump and Zaheer-Ud-Din Babar

Reimbursement policy optimization for Angiotensin-converting enzyme (ACE) inhibitors in Bulgaria: Controlling expenditure without undermining access to treatment

Authors: Rossen M Kazakov and Penka I Petrova

Prices of oncology medicines in European countries, Australia and New Zealand

Authors: Sabine Vogler, Agnes Vitry and Zaheer Ud-Bin-Babar

Collaborative models for increasing efficiency of early drug assessment

Authors: Anna Nachtnebel and Claudia Wild

Value of generic medicines: an health economics study

Authors: Martin Albrecht, Ariane Höer and Anne Zimmermann

Cost-Containment of Non-Formulary Medicines Accessibility: Malaysian Experience

Authors: Nur Liyana Zainal Bahrin, Yahaya Hassan, Abu Bakar Abd Majeed, Nur Wahida Zulkifli and Azlan Ahmad

Why we should have more collaboration on HTA in Europe: the example of sofosbuvir

Authors: Hedi Schelleman, Rudy Dupree, Finn B Kristensen and Wim Goettsch

Socioeconomic determinants of medicines use in Central Eastern Europe: the role of pharmaceutical policy in reducing inequalities

Authors: Sabine Vogler, August Österle and Susanne Mayer

Development of pharmaceutical prices in the Republic of Macedonia in comparison to selected countries outside the national reference baskets

Authors: Kristina Hristova and Claudia Habl

Price changes of antibiotics and perceived substitutes in the context of OTC policy changes in Mexico and Brazil

Authors: Yared Santa-Ana-Tellez, Veronika J Wirtz, Hubert GM Leufkens and Aukje K Mantel-Teeuwisse

Introduction of generic substitution and reference pricing in Ireland: early effects on state pharmaceutical expenditure and generic penetration, and associated success factors

Authors: Susan Spillane, Cara Usher, Kathleen Bennett, Roisin Adams and Michael Barry

Availability and affordability of medicines for children

Authors: Irina Kazaryan and Lusine Vardanyan

Policy options to deal with high-cost medicines – survey with European policy-makers

Authors: Nina Zimmermann, Sabine Vogler and Hanne Bak Pedersen

Applying Multiple Criteria Decision Analysis (MCDA) in the context of HTA: an experimental case study on metastatic colorectal cancer

Authors: Aris Angelis and Panos Kanavos

Retrospective financial analysis of medicines reimbursement services in community pharmacy

Authors: Elena Chitan

Access to subsidised medicines, cost of medicines and health outcomes: exploring general practitioners' perceptions and experiences

Authors: Zaheer-Ud-Din Babar, Abdul Ali, Christine Kim, James Mcintosh, Malaika Samuel Namdas, Erica Lourdes Rodrigues, Komal Vallabh and Anne Rew

Pharmaceutical policies in Australia and New Zealand

Authors: Zaheer-Ud-Din Babar

The Pharmaceutical Pricing and Reimbursement Information (PPRI) network – a decade of exchange of information and policy research?

Authors: Sabine Vogler, Nina Zimmermann and Kees De Joncheere

Impact of delisting OTC medicines from reimbursement list

Authors: Petra Chytilová and Robin Šebesta

Impact of discounts on medicine prices

Authors: Peter Schneider and Sabine Vogler

Policy cooperation and interface issues

Authors: Sabine Vogler, Nina Zimmermann, Veronika J Wirtz and Zaheer-Ud-Din Babar

Pharmaceutical pricing and reimbursement policies: perspectives for the future

Authors: Andrew L Gray

Managing new premium-priced medicines in Europe

Authors: Govin Permanand and Hanne Bak Pedersen

Policies beyond the crisis: lesson learned

Authors: Sabine Vogler, Nina Zimmermann, Veronika J Wirtz and Zaheer-Ud-Din Babar

Impact of Generic Price Linkage System and Reference Price System on prices of pharmaceuticals – comparison of Austria and Finland

Authors: Jaana E Martikainen, Timo Maljanen, Hanna Koskinen and Sabine Vogler

Adapting pharmaceutical reimbursement policies to manage spending on high-priced drugs

Authors: Elizabeth Docteur and Ruth Lopert

Challenges and opportunities for pharmaceutical pricing and reimbursement policies

Authors: Sabine Vogler, Nina Zimmermann, Alessandra Ferrario, Veronika J Wirtz and Zaheer-Ud-Din Babar

Affordable innovation: future directions in pharmaceutical policy

Authors: Suzanne R Hill

Unintended consequences of co-payment regulations in Belgium: the case of atorvastatin

Authors: Jessica Fraeyman, Hans De Loof, Guido Van Hal, Guido De Meyer, Roy Remmen and Philippe Beutels

Accrediting retail drug shops to strengthen Tanzania’s public health system: an ADDO case study

Retail drug sellers are a major source of health care and medicines in many countries. In Tanzania, drug shops are widely used, particularly in rural and underserved areas. Previously, the shops were allowed t...

Authors: Edmund Rutta, Jafary Liana, Martha Embrey, Keith Johnson, Suleiman Kimatta, Richard Valimba, Rachel Lieber, Elizabeth Shekalaghe and Hiiti Sillo

Policy versus practice: a community-based qualitative study of the realities of pharmacy services in Nunavut, Canada

Nunavut is an Arctic territory in Canada subject to many social, economic and health disparities in comparison to the rest of the nation. The territory is affected by health care provision challenges caused by...

Authors: Sandra J. Romain, Jillian C. Kohler and Kue Young

Access to and quality use of non-communicable diseases medicines in Nepal

Noncommunicable diseases are a major healthcare problem in Nepal and their burden is increasingevery year. Noncommunicable diseases (NCDs) bring additional challenges to the Nepalese healthcaresystem which is ...

Authors: Bhuvan K.C., Susan Heydon and Pauline Norris

Parents’ preferences and willingness-to-pay for human papilloma virus vaccines in Thailand

To examine parents’ preferences and willingness-to-pay (WTP) for HPV vaccines.

Authors: Surachat Ngorsuraches, Kornwan Nawanukool, Krittin Petcharamanee and Ungkanit Poopantrakool

Explaining the slow transition of child-appropriate dosage formulations from the global to national level in the context of Uganda: a qualitative study

In 2007, the Sixtieth World Health Assembly (WHA) passed a resolution entitled “Better medicines for children” and subsequently the World Health Organization (WHO) recommended the inclusion of child-appropriat...

Authors: Xavier Nsabagasani, Ebba Hansen, Anthony Mbonye, Freddie Ssengooba, Herbert Muyinda, James Mugisha and Jasper Ogwal-Okeng

Trends in the utilization of antihypertensive medications among Palestine refugees in Jordan, 2008-2012

The purpose of this study is to describe trends in the utilization of antihypertensive medications, overall and by type of medication, specifically thiazide diuretics, as well as uncontrolled hypertension, in ...

Authors: Rawan Saadeh, Dima Qato, Ali Khader, Yousef Shahin and Akihiro Seita

Community pharmacists’ attitudes toward the quality and price of locally manufactured generic medicines in Kabul, Afghanistan

To report the attitudes of community pharmacists in Kabul, Afghanistan, concerning the quality and price of locally manufactured medicines.

Authors: Mohammad Bashaar, Mohamed Azmi Hassali and Fahad Saleem

Availability and utilization of the WHO recommended priority lifesaving medicines for under five-year old children in public health facilities in Uganda: a cross-sectional survey

To explore the availability and utilization of the World Health Organization (WHO) recommended priority life-saving medicines for children under five in public health facilities in Uganda.

Authors: Xavier Nsabagasani, Jasper Ogwal-Okeng, Anthony Mbonye, Freddie Ssengooba, Simon Muhumuza and Ebba Holme Hansen

Utilization of oral antidiabetic medications in Taiwan following strategies to promote access to medicines for chronic diseases in community pharmacies

Taiwan’s National Health Insurance (NHI) has encouraged physicians to use “chronic medication prescriptions” for patients with stable chronic diseases since 1995. Patients are allowed to refill such prescripti...

Authors: Jason C Hsu, Dennis Ross-Degnan, Anita K Wagner, Ching-Lan Cheng, Yea-Huei Kao Yang, Fang Zhang and Christine Y Lu

Tenofovir substitution in Namibia based on an analysis of the antiretroviral dispensing database

In the management of HIV infection, tenofovir is preferred to its predecessors – zidovudine and stavudine – in the antiretroviral therapy (ART) nucleoside backbone. Tenofovir’s (TDF) preference is based on its...

Authors: Francis Kalemeera, Assegid T Mengistu and Johannes Gaeseb

Assessment of a revolving drug fund for essential asthma medicines in Benin

Benin established a revolving drug fund (RDF) for essential asthma medicines in 2008. We evaluated the operation of the RDF and assessed whether there was interruption of supply of asthma medicine from 2008 to...

Authors: Gildas Agodokpessi, Nadia Aït-Khaled, Martin Gninafon, Leon Tawo, Wilfried Bekou, Christophe Perrin, Karen Bissell, Nils Billo, Donald A Enarson and Chen-Yuan Chiang

The reality of task shifting in medicines management- a case study from Tanzania

Tanzania suffers a severe shortage of pharmaceutical staff. This negatively affects the provision of pharmaceutical services and access to medicines, particularly in rural areas. Task shifting has been propose...

Authors: Karin A Wiedenmayer, Ntuli Kapologwe, James Charles, Fiona Chilunda and Siana Mapunjo

Knowledge and perceptions of physicians from private medical centres towards generic medicines: a nationwide survey from Malaysia

Generic medicine prescribing has become a common practice in public hospitals. However, the trend in private medical centres seems to be different. The objective of this study was to investigate knowledge, per...

Authors: Rohit Kumar, Mohamed Azmi Hassali, Fahad Saleem, Alian A Alrasheedy, Navneet Kaur, Zhi Yen Wong and Muhamad Ali SK Abdul Kader

Farmácia Popular Program: changes in geographic accessibility of medicines during ten years of a medicine subsidy policy in Brazil

The Brazilian constitution guarantees the right to health, including access to medicines. In May 2004, Brazil’s government announced the “Farmácia Popular” Program (FPP) as a new mechanism to improve the Brazilia...

Authors: Isabel Cristina Martins Emmerick, José Miguel do Nascimento Jr, Marco Aurélio Pereira, Vera Lucia Luiza and Dennis Ross-Degnan